Botulinum Toxins for Facial Wrinkles: Beyond Glabellar Lines

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 1, 2007, Pages 41-49

  Dayan, Steven H ^a   Maas, Corey S ^b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Maas Clinic   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; COLLAGEN; HYALURONIC ACID; HYDROXYAPATITE; UNCLASSIFIED DRUG; VISTABEX;

CLINICAL TRIAL; CRANIOFACIAL MORPHOLOGY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSPHAGIA; DYSPHONIA; FACE; HUMAN; INJECTION SITE; INJECTION SITE PAIN; MUSCLE WEAKNESS; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW; WRINKLE;

BOTULINUM TOXIN TYPE A; FACE; FOREHEAD; HUMANS; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 33847059141     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.12.001     Document Type: Review

References (29)

1. Niamtu III J. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 61 3 (2003) 317-324
2. Rohrich R.J., Janis J.E., Fagien S., et al. The cosmetic use of botulinum toxin. Plast Reconstr Surg 112 Suppl 5 (2003) 177S-188S [quiz 188S, 192S; discussion 189S-91S]
3. Kane M.A. The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg 21 1 (2005) 55-64
4. Kim N., Chung J.H., Park R.H., et al. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 115 3 (2005) 919-930
5. Carruthers J., and Carruthers A. Botulinum toxin A in the mid and lower face and neck. Dermatol Clin 22 2 (2004) 151-158
6. Ramirez A.L., Reeck J., and Maas C.S. Preliminary experience with botulinum toxin type B in hyperkinetic facial lines. Plast Reconstr Surg 109 6 (2002) 2154-2155
7. Ramirez A.L., Reeck J., and Maas C.S. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg 126 (2002) 459-467
8. Kim E.J., Ramirez A.L., Reeck J.B., et al. The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines. Plast Reconstr Surg 112 Suppl 5 (2003) 88S-93S [discussion 94S-97S]
9. de Almeida A, Marques E, de Almeida J, et al. Pilot study comparing the diffusion characteristics of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Poster presented at the 64th Annual Meeting of the American Academy of Dermatology. San Francisco, March 3-7, 2006.
10. Flynn T.C., and Clark R.E. Botulinum toxin type b (MYOBLOC) versus botulinum type a (BOTOX) frontalis study; rate of onset and radius of diffusion. Dermatol Surg 29 5 (2003) 519-522
11. Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg 112 Suppl 5 (2003) 6S-18S [discussion 19S-20S]
12. Carruthers J., Fagien S., Matarasso S.L., et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114 Suppl 6 (2004) 1S-22S
13. Lowe N.J., and Yamauchi P. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol 22 1 (2004) 18-22
14. Vartanian A.J., and Dayan S.H. Facial rejuvenation using botulinum toxin A: review and updates. Facial Plast Surg 20 1 (2004) 11-19
15. Spósito M.M. New indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg 110 2 (2002) 601-611 [discussion 612-13]
16. Vartanian A.J., and Dayan S.H. Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am 13 1 (2005) 1-10
17. Kane M.A. The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 112 Suppl 5 (2003) 66S-72S [discussion 73S-74S]
18. Dayan S.H., and Kempiners J.J. Treatment of the lower third of the nose and dynamic nasal tip ptosis with Botox. Plast Reconstr Surg 115 6 (2005) 1784-1785
19. ® for the treatment of subjects with chin rhytids. J Drugs Dermatol 4 4 (2005) 417-422
20. Kane M.A. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg 103 2 (1999) 656-663 [discussion 664-5]
21. Kane M.A. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A revisited. Plast Reconstr Surg 112 Suppl 5 (2003) 125S-126S
22. Brandt F.S., and Bellman B. Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 24 11 (1998) 1232-1234
23. Matarasso A., Matarasso S.L., Brandt F.S., et al. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 103 2 (1999) 645-652 [discussion 653-5]
24. Bikhazi N.B., and Maas C.S. Refinement in the rehabilitation of the paralyzed face using botulinum toxin. Otolaryngol Head Neck Surg 117 4 (1997) 303-307
25. Ahn J., Horn C., and Blitzer A. Botulinum toxin for masseter reduction in Asian patients. Arch Facial Plast Surg 6 3 (2004) 188-191
26. Choe S.W., Cho W.I., Lee C.K., et al. Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 31 5 (2005) 502-507 [discussion 507-8]
27. Macdonald M.R., Spiegel J.H., Raven R.B., et al. An anatomical approach to glabellar rhytids. Arch Otolaryngol Head Neck Surg 124 12 (1998) 1315-1320
28. Loos B.M., and Maas C.S. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am 11 (2003) 439-443
29. Matarasso A. Discussion. New indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg 110 2 (2002) 612-613